News
FDA accelerates BGB-16673 for CLL, SLL
According to BeiGene, the maker of the new drug, the Food and Drug Administration (FDA) will accelerate BGB-16673 for the
3 Minute
September 20, 2024
According to BeiGene, the maker of the new drug, the Food and Drug Administration (FDA) will accelerate BGB-16673 for the